expression studies of DSC2 missense mutations as well as immunohistochemistry of diseased myocardium have demonstrated a reduction of functional DSC2 at the desmosome attributable to impaired maturation and diminished junctional signals of JUP and gap junction protein connexin 43 (Cx43) as well as altered binding properties of both proteins. [19] [20] [21] [22] Although the effect of extracellular nonsense mutations in DSC2 was proposed to produce nonfunctional alleles, this was not further investigated.
The Hutterites are an Anabaptist religious isolate who originated in 16th-century Europe and emigrated to the United States and Canada in the 1870s. 23, 24 Today, the ≈44 000 Hutterites living in North America can be traced back to <100 founders. There are 3 branches (also known as leut) of Hutterites: Dariusleut (D-leut), Lehrerleut (L-leut), and Schmiedeleut (S-leut). Marriages among the 3 leut have been uncommon over the last 100 years. 23, 24 Here, we describe a founder mutation (p.Q554X) in desmocollin-2 showing severe early onset biventricular arrhythmogenic cardiomyopathy in homozygous Hutterite individuals. Population-based studies indicate a heterozygous carrier frequency of 1 in 10.6 individuals for the mutant DSC2 allele.
Immunohistochemistry of diseased myocardium and recombinant expression in cell culture showed that the extracellular truncated protein remains stable, partially processed and localized at the intercalated discs, suggesting a more complex mechanism with partial contribution in maintaining cell junction integrity rather than the expected complete loss of function attributable to nonfunctional alleles.
Methods

Patients and Clinical Characterization
The study was approved by the Local Ethics Committee (REB-ID: 23441), and all individuals provided written informed consent. Clinical evaluation included 12-lead ECG, signal-averaged ECG, exercise testing according to the Bruce protocol, 24-hour Holter monitoring, and 2-dimensional echocardiography or cardiac MRI. Diagnosis of ARVC was based on the 2010 revised TFC. 4
Genetic Studies
The index case (D-III/12) was screened for mutations in exons including exon/intron boundaries of PKP2, DSC2, DSG2, DSP JUP, and DES as well as for the TMEM43 S358L mutation by Sanger sequencing of polymerase chain reaction (PCR)-amplified genomic fragments using an ABI-3100 Genetic Analyzer and Genotyper software (ABI PRISM 3100 Genetic Analyzer, Foster City, CA). Other family members underwent targeted mutation analysis for the DSC2 c.1660C>T (p.Q554X) mutation. The population-based sample of 1535 Schmiedeleut subjects was analyzed as described previously. 25 The DSC2 p.Q554X mutation was genotyped using TaqMan Assayon-Demand (Applied Biosystems, Foster City, CA), according to the manufacturer protocols. Genotypes were analyzed using the allelic discrimination software of the 7900 HT Fast Real-Time PCR system (Applied Biosystems). Mendelian errors were identified by Pedcheck 26 and were either corrected or the implicated nuclear families were removed from further analyses if the error could not be unambiguously resolved. Genotypes were in Hardy-Weinberg equilibrium, using a test that adjusts for the Hutterite population structure and relatedness. 27
Histology and Immunohistochemistry of Endomyocardial Biopsies
Endomyocardial biopsies were taken from the RV septum and either cryo-(D-III/20) or paraffin (D-III/21, L-II/4) embedded. Deparaffinized and rehydrated paraffin-embedded sections were antigen unmasked with sodium citrate buffer and blocked with 5% goat serum and incubated with primary antibodies overnight at 4°C. Cells on glass coverslips and frozen tissue sections were fixed in 4% paraformaldehyde, permeabilized with PBS 1% TritonX-100 blocked in 5% BSA, and incubated with primary antibodies. Secondary antibodies, donkey antirabbit, mouse, and rat IgG were conjugated with Alexa Fluor 488 or 555. Samples were mounted with ProLong Gold antifade containing 4',6-diamidino-2-phenylindole (Invitrogen) and visualized using laser scanning confocal microscopy (SP5, Leica). The primary antibodies used were mouse monoclonal antibodies against PKP2, DSP, DSG2 (all Progen, Heidelberg, Germany), JUP, N-cadherin (NCAD), Cx43 (all BD Bioscience Clontech, Franklin Lakes, NJ), N-terminal DSC22/DSC3 (Invitrogen, #32-6200), and alpha tubulin (SIGMA-Aldrich); rabbit polyclonal antibodies against NCAD, JUP, green fluorescent protein (all Santa Cruz; Santa Cruz, CA), and C-terminal DSC2 (SIGMA-Aldrich, #HPA012615). We performed isotype control staining of cryo-and paraffin-embedded heart tissue with either mouse antihuman IgG1 A10630 or rabbit isotype control REF086199 (both Invitrogen) showing no specific stain as well as no significant background stain (data not shown). Importantly, we assessed the physical localization of DSC2 at the intercalated disc by costaining with NCAD.
Generation of cDNA Constructs
The human DSC2 (DSC2b) cDNA (NM_004949) was PCR amplified without a stop-codon using Pfu polymerase (Stratagene, La Jolla, CA) and cloned into the pENTR/D-Topo vector (Invitrogen, Gateway system). The mutant DSC2 construct was generated by PCR amplification of only the first 1660 bp of the human DSC2 cDNA and also cloned into the pENTR/D-Topo vector (Invitrogen Gateway System). A second mutant construct was generated by PCR mutagenesis by introducing the c.1660T mutation into the DSC2 cDNA and direct bacterial transformation. All pENTR-constructs were verified by sequencing and shuttled into the pcDNA-DEST53 expression vector containing a c-terminal GFP (Invitrogen). The constructs of wild-type (WT) PKP2 and mutant PKP2 (C796R) were generated as previously described. 28
Cell Culture and Transfections
HeLa and HEK293 cell lines were maintained in DMEM supplemented with 10% fetal bovine serum at 37°C in a 5% CO 2 incubator. Both cell lines were transfected using polyethylenimine (CELLnTEC) in accordance with the manufacturer recommendations. All transfected cells were analyzed for expression of the recombinant proteins 48 hours after transfection. Indirect immunofluorescence and confocal microscopy were performed as described above. The immunoblot was performed as previously described. 28 
Results
Early Onset Biventricular Arrhythmogenic Cardiomyopathy in the Hutterite Population
We report 2 extended families of the Dariusleut and Lehrerleut branch of the Hutterite population with a history of sudden death in children while swimming or playing hockey ( Figure 1 ; Table I in the online-only Data Supplement). Autopsies in 2 individuals aged 14 years (D-III/16, L-III/22) showed marked dilatation of the left ventricle (LV) and RV with myocardial replacement by fibrous and fatty tissue, predominantly in a subpericardial distribution. The cause of death was reported as typical for ARVC with major left ventricular involvement.
Further clinical evaluation and pedigree analyses identified several individuals who presented with early onset cardiomyopathy and arrhythmias ( Table I in the online-only Data Supplement). All of them were evaluated according to the 2010 TFC 4 for ARVC and fulfill the criteria for the disease. However, the majority of cases (D-III/20, L-II/4, L-III/21, L-III/12) were initially diagnosed with idiopathic dilated cardiomyopathy or congenital aneurysms because of the impressive LV involvement with regional wall thinning and localized aneurysms reported by echocardiography or cardiac MRI.
The most interesting imaging features correspond to patient D-III/20. He presented at 21 years of age with a fall from a ladder at work and was found unconscious but recovered after a few seconds. His cardiac MRI demonstrated a very abnormal LV with a basal inferior aneurysm and additional small regions of wall thinning with akinesis in the apical anterior and anterolateral wall segment. Contrast uptakes in the late Gadolinium enhancement images were consistent with transmural fibrosis ( Figure IA 1 2  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28   1  2  3  4  5  6  7  8  9  10 involvement was documented for patients L-II/4, L-III/21, and D-III/21, although in those patients the RV was also severely dilated with increased RV end-diastolic volume index/BSA indicating biventricular cardiomyopathy ( Table  I in the online-only Data Supplement). Patient D-III/12 was the only 1 with a predominantly right ventricular involvement. Akinetic LV and RV apex was a common imaging feature of all 5 affected patients. Overall, only 3 out of 5 living affected individuals fulfilled a major criterion given for structural and functional alterations assessed by cardiac MRI. Although severely affected, the siblings D-III/20 and D-III/21 did not fulfill imaging criterion based on the current TFC for ARVC.
Twelve-lead ECGs of all affected patients consistently showed T-wave inversions in the right precordial leads; 4 individuals had T-wave inversions in inferior and lateral leads as well ( Figure IC in the online-only Data Supplement). Epsilon waves were seen in individuals L-III/21 and L-III/12. Five patients had late potentials on signal-averaged ECGs.
Ventricular arrhythmias of left bundle-branch block morphology with superior and inferior axes have been documented in almost all affected individuals leading to an implantable cardioverter-defibrillator implantation. Four patients had RV-biopsies, but the histology for all 4 was not diagnostic for ARVC based on the revised TFC. Interestingly, there is no evidence for hair abnormalities such as woolly hair or overt palmoplantar keratoderma. However, very mild signs of a palmar hyperkeratosis could be observed in patient D-III/20, but, compared with his heterozygous parents, it is questionable if those changes are primary or secondary to manual farm work ( Figure IIA and IIB in the online-only Data Supplement).
Identification of a Homozygous DSC2 Mutation (p.Q554X) in all 3 Branches of the Hutterite Population
Genetic analysis of all known disease genes for ARVC identified a homozygous truncation mutation in DSC2: c.1660C>T (p.Q554X) in individual D-III/12 ( Figure 2 ) and in all other living clinically affected subjects as indicated in Table I in the online-only Data Supplement.
Parents of homozygous individuals were genotyped and found to be heterozygous for the DSC2 mutation. One parent (D-II/11) who died unexpectedly at 54 years of age was not available for genotyping. An autopsy was not performed.
Extensive family history and pedigree reconstruction revealed that homozygous individuals live in colonies located in Southern Alberta and Saskatchwan and are members of 2 different Hutterite branches: the Dariusleut and Lehrerleut 23 ( Figure 1A and 1B). The heterozygous parents are distantly related to each other. There are reported histories of sudden deaths in young children such as a 9-year-old (D-III/1) who died while swimming and 3 siblings under 16 years of age (L-III/26-28) who also died unexpectedly. Further genotyping identified several heterozygous individuals in both families as indicated in Figure 1 . Even when carrying, the heterozygous mutation is counted as 1 major criterion, none of the clinically assessed heterozygotes fulfilled the TFC for ARVC. There were few individuals with either a minor criterion for late potentials in the signal-averaged ECG or one based on the count of premature ventricular beats.
To determine the carrier frequency of the p.Q554X mutation, we genotyped a population-based sample of 1535 subjects from the Schmiedeleut Hutterites from South Dakota. We identified 144 heterozygotes, yielding a carrier frequency of 9.4% (144/1535 or 1 in 10.6). Moreover, 6 homozygotes, 18 to 55 years of age, in 4 families were present in this sample. The first family included 3 homozygous siblings (18, 19 , and 21 years of age); 1 of them had a history of 2 syncopal episodes while riding a bike. The second family included a 42-year-old female with no personal medical history, but had a sister who died at 35 years of age during pregnancy because of heart failure. Genotyping was not available in the sister. A 55-year-old individual in a third family reported a history of arrhythmias 10 years ago, but without further clinical evaluation. Finally, a 26-yearold individual in a fourth family had an enlarged RV with RV dysfunction during a previous echocardiogram. The 6 homozygous individuals inherited the mutation on a shared 2.3 Mb haplotype (chr18:28061189-30339291) flanking DSC2. All 144 Schmiedeleut carriers could be traced through a 9-generation pedigree back to their most recent common ancestor couple who was born in the 1750s, before the establishment of the 3 Hutterite leut. Collectively, the shared haplotype and shared common ancestor couple suggests that the mutation was introduced in the S-leut Hutterites by a single individual.
Mutant DSC2 Protein Remains Stable and Located at the Intercalated Discs in Cardiac Biopsy Samples
Endomyocardial biopsy samples from 3 homozygous individuals (D-III/20, D-III/21, L-II/4) were analyzed for the expression of DSC2, other desmosomal proteins, and Cx43 by immunohistochemistry. Surprisingly, we were able to detect the mutant DSC2 protein at the intercalated discs by using an N-terminal specific DSC2 antibody in homozygous biopsy samples ( Figure 3A and 3C) . The truncated DSC2 protein remains stable and is localized at or near the intercalated discs. However, a more detailed review of the biopsy tissue of patient L-II/4 and to some lesser extent of patient D-III/21 showed a subtle defect in the colocalization of DSC2 with NCAD in the merged images. In the control tissue, DSC2 was completely colocalized with NCAD, yielding an exclusive yellow pattern of colocalization. This contrasted in pattern to the homozygous patient L-II/4, where there was subtle spatial separation between the NCAD staining and the DSC2 staining elements within the intercalated discs, indicating an altered expression or processing of the mutant protein ( Figure 3A , inset). In addition, patient DIII/21also showed colocalization with NCAD in the merged images, but the overlay appeared slightly more yellow than in the control sample, which might be related to a decreased intensity of the DSC2 immunoreactive signals.
Because the p.Q554X mutation truncates DSC2 at the 4th extracellular domain and the truncated protein thereby lacks the 5th extracellular domain, transmembrane, and intracellular domains ( Figure 2B ), the analysis was repeated with a C-terminal specific DSC2 antibody. As expected, the C-terminal antibody failed to detect the mutant DSC2 protein in biopsy samples of the 3 patients ( Figure 3B and 3C) . None of the other desmosomal proteins were found to be significantly altered (data not shown); however, the expression of JUP appeared to be slightly reduced in subject L-II/4 compared with NCAD and the control sample ( Figure III in the online-only Data Supplement).
In addition, we looked for changes in the expression pattern of the gap junction protein Cx43. Immunofluorescence analysis of the endomyocardial biopsies revealed almost unchanged Cx43 expression levels in both patients compared with levels of NCAD serving as an internal control ( Figure IV in the online-only Data Supplement).
In Vitro Expression Studies of the Mutant DSC2 Protein Confirms Its Stable Expression
To study the effect of the p.Q554X mutation on protein stability and cellular localization in vitro, we transfected HEK293 cells with constructs expressing human DSC2 WT or mutant DSC2-Q554X. Because the functional DSC2 is a product of endogenous proteolytic cleavage of the signal and propeptides, 19, 20, 22 we tagged the recombinant proteins with a c-terminal GFP. The expression levels of the DSC2-WT and DSC2-Q554X proteins could be detected at similar levels, suggesting that the mutant protein is intrinsically stable. Western blot analyses showed 2 bands of the truncated mutant protein at an estimated size of 75 kDa; the uncleaved precursor form (P) and the cleaved mature form (M) of 71% versus 29%, respectively, whereas the WT protein was almost only detected in its mature form ( Figure 4A-4C ).
Immunocytochemical analyses of transfected HEK293 cells revealed that both DSC2-WT and DSC2-Q554X are localized at the cell membrane, confirming the expected location of the mature form of both proteins. In addition, the mutant protein showed a diffuse cytoplasmic staining, presumably vesicular suggesting the expression pattern of the uncleaved precursor protein ( Figure 4D ).
DSC2 is proposed to interact with DSG2 extracellularly, 16 whereas its cytoplasmic domain interacts with PKP2 and JUP 29 ( Figure 2B ). Interestingly, after cotransfection of HeLa cells lacking endogenous DSC2 and PKP2 with either DSC2-WT or mutant DSC2 and PKP2-WT, cell border localization of both WT and mutant DSC2 could be observed, although the mutant protein lacks the proposed binding site for PKP2 ( Figure 2B ; Figure VD 
Discussion
Here, we show that homozygosity of a truncation mutation (p.Q554X) in the desmosomal cadherin DSC2 causes an early onset arrhythmic cardiomyopathy in the North American Hutterite population with a carrier frequency of 9.4% among Schmiedeleut Hutterites. The sharing of a 2.3 Mb C common haplotype and an ancestor couple in the S-leut suggests that it is a founder mutation in that subgroup. Immunostaining of cardiac biopsy samples from patients revealed localization of the truncated extracelluar DSC2 protein at the intercalated discs consistent with in vitro expression in cell lines showing a stable, partially processed mutated protein located at the cell membrane in addition to diffuse cytoplasmic distribution. The distinct cardiac phenotype observed in the homozygous DSC2 mutation carriers, characterized by the impressive mainly left-sided aneurysms and the membranelike wall thinning, was not clinically recognized as ARVC in some of the affected patients. However, retrospectively, there are clear phenotypic overlaps with dominant inherited arrhythmogenic cardiomyopathy, as well as recessive disorders such as Naxos disease and Carvajal syndrome. In contrast to those recessive cardiocutaneous syndromes where either JUP or DSP are mutated, homozygous DSC2 mutation carriers do not exhibit an obvious hair or skin phenotype. There are some mild abnormalities of the skin that, in comparison with heterozygous carriers, are more likely related to the extended physical work on a farm. Although we cannot exclude these changes at the histological level, we could not find palmoplantar keratoderma and wooly hair similar to Naxos disease or Carvajal syndrome. Interestingly, a recent report of Simpson et al 30 described another frameshift mutation (p.S614fsX625) in DSC2 causing ARVC, mild palmoplantar keratoderma, and wooly hair in a family of Pakistani origin, indicating that an involvement of hair and skin seems possible but might be dependent on the exact location of the mutation or a modifying genetic/ethnic background. In contrast to JUP and DSP, which are expressed in all desmosome containing tissues including the skin, DSC2 is the only expressed DSC isoform in the heart. 31, 32 There are 2 other isoforms (DSC1 and DSC3) expressed in different layers of epithelial tissue 33 that might compensate for the truncated DSC2 protein explaining the milder or absent skin and hair phenotype.
Remarkably, previously described missense and premature stop-codon mutations in DSC2 are known to cause dominant ARVC. [17] [18] [19] [20] [21] However, ongoing clinical evaluation of heterozygous carriers of the p.Q554X mutation could not detect individuals fulfilling TFC criteria 4 for ARVC. There is 1 case of unexpected sudden death at 54 years of age (D-II/11) in an obligate carrier who was not genotyped or phenotyped before he passed away. Given the very high carrier frequency of 1/10.6 in the S-leut and an estimated population of ≈44 000 Hutterites living in North America, further clinical investigations are needed to rule out a codominant or recessive disease pattern and specify the risk for severe arrhythmias in heterozygous people.
Interestingly, even the cardiac phenotype in homozygous carriers seems quite variable. There are individuals in their fourth and fifth decades of life with moderate disease severity, raising the question of a potential protective modifier gene in this population.
Overall, our findings confirm the suggested clinical and genetic variability and complexity of arrhythmogenic cardiomyopathy. Our findings also confirm that the disease-causing mutation is only 1 predisposing factor in the pathogenesis of the disease. Given the homogenous genetic background of the Hutterite population, the broad clinical disease expression seems even more remarkable. Additionally, we provide further evidence for the involvement of both ventricles, which has previously been shown especially for dominant and recessive DSP mutations 11, 13, 34 and for the p.Arg14del mutation in phospholamban. 35 The next remarkable finding was the unexpected stable, but altered, expression of the truncated DSC2 protein lacking the transmembrane and all intracellular domains and its localization at the intercalated discs, which we observed in endomyocardial biopsy samples of 3 affected patients (Figure 3 ). Immunofluorescent images from a cryoembedded biopsy of patient D-III/20 clearly showed no differences in the expression pattern and levels of DSC2 compared with the control sample ( Figure 3C ), whereas the images of paraffin-embedded cardiac tissue, of patient L-II/4, in particular, and of patient D-III/21, demonstrated an imperfect colocalization pattern at the intercalated discs as well as reduced levels of the truncated DSC2 protein ( Figure 3A and 3B) .
To our knowledge, there are no in vivo or in vitro expression data of N-terminal DSC2 mutations truncating the protein within the extracellular domains available mainly because those mutations are predicted to generate nonfunctional alleles. Even if the truncated proteins are expressed, they should be unable to anchor the plasma membrane. Surprisingly, our data indicate that to some extent the truncated protein remains stable and can be localized at the intercalated discs. To confirm our in vivo findings, we expressed the p.Q554X mutant protein in HEK293 cells, which revealed the truncated protein remains stable and at least partially localized at the cell membrane in addition to cytoplasmic (likely vesicular) distribution ( Figure 4D ). Western Blot analyses showed that there is no difference in the overall levels of expression of WT and mutant proteins but detected that the mutant protein was only partially processed as a mature protein ( Figure 4B and 4C) . Other pathogenic missense mutations in DSC2 (R203C and T275M) also remain stable and can result in total or partial retention of DSC2 in the preprotein form. 20 Proteolytic processing and maturation of cadherins are found to occur when they are localized on the cell membrane. Cadherins are also known to acquire their adhesive property after being processed into the mature form, suggesting that our mutant DSC2 might lack adhesive function. 22, 36 Given that the p.Q554X protein seems to be partially processed at the cell membrane, it remains to be determined whether it is integrated into the desmosome complex by interacting with ≥1 desmosomal proteins, perhaps with DSG2. It is more likely to be processed, secreted into the extracellular space, and then bound in trans to DSG2 of the adjacent cell.
Interestingly, after cotransfection of desmosome-free HeLa cells with either WT DSC2 or mutant DSC2 and PKP2, cell border localization of both WT and mutant DSC2 could be observed, although the mutant protein lacks the proposed binding site for PKP2 ( Figure 2B ; Figure V in the online-only Data Supplement), suggesting complex signaling processes in trafficking and desmosome assembly. It has been recently demonstrated that DSG2 and DSC2 both exhibit microtubuledependent transport in epithelial cells but use distinct motors to traffic to the plasma membrane. 37 According to the authors, however, PKP2 is required for the longrange transport of DSC2. Whether it is by direct interaction or because of other signaling processes needs to be further determined.
Altered distribution of desmosomal proteins, especially JUP as well as gap junction remodeling, has been previously reported in immunohistochemical studies of diseased human myocardium. 19, 38, 39 Surprisingly, we found no major alterations in the expression of other desmosomal proteins, in particular not of JUP in cardiac tissue of our homozygous patients. The expression level and pattern of JUP in patient D-III/21 was completely unaltered. While patient L-II/4 showed a diminished immunoreactive signal of JUP, the costaining with NCAD also remained reduced compared with the control sample ( Figure III in the online-only Data Supplement). Limitations of this study include the small amount of tissue available for immunofluorescent analyses, allowing for staining of very few sections. Furthermore, we used biopsy samples that only represent a small tissue area of the RV septum. It is also noted that the histological analyses of the biopsies of all 3 patients did not reveal abnormalities diagnostic for ARVC ( Table I in It has been shown that abnormal intercellular adhesion caused by mutations in desmosomal proteins affects gap junction remodeling by a reduced expression of the major gap junction protein Cx43 in patients with dominant ARVC as well as in Naxos and Carvajal syndrome. 3, 14, 38, 39 There is some evidence that the diminished Cx43 expression is an effect distinct to the disease mechanism rather than associated with structural cardiac remodeling in advanced disease. However, immunofluorescence analysis of Cx43 revealed almost unchanged immunoreactive signals and localization in cardiac tissue of 2 homozygous carriers compared with NCAD and the expression pattern of the control sample ( Figure IV in the online-only Data Supplement). This seems conflicting with previous findings in patient tissue, but again our analysis was performed on few sections attributable to the limited amount of patient issue. A more exact quantification of total Cx43 protein levels by Western blot analysis remains open for study. Previous findings reported by Gehmlich et al in a patient carrying p.Q851fsX855 variant showed reduced total protein levels by Western blotting but normal localization and distribution at the intercalated discs.
To conclude, homozygosity of an extracellular truncation mutation (p.Q554X) in DSC2 leads to cardiac-restricted phenotype and arrhythmic cardiomyopathy in the North American Hutterite population. The phenotype of localized aneurysms and wall thinning predominantly of the LV provides further evidence that DSC2 mutations not only lead to classical ARVC but also to a left and biventricular cardiomyopathy.
Because both alleles are affected in homozygous individuals, the truncation within the fourth extracellular domain leads to complete loss of full-length intact DSC2. Instead, the truncated DSC2 protein was detectable at the intercalated discs in cardiac biopsies of patients. Moreover, in vitro expression data confirm a stable, partially processed, and membrane-localized truncated protein, which suggests the potential role of DSC2 in maintaining desmosome integrity and function.
